Safety of administering biologics to IBD patients at an outpatient infusion center In New York City during the COVID-19 pandemic: Sars-CoV-2 seroprevalence and clinical and social characteristics

Serre-Yu Wong, Stephanie Gold, Emma K. Accorsi, Tori L. Cowger, Dean Wiseman, Reema Navalurkar, Rebekah Dixon, Drew S. Helmus, CiTI Study Group, Adolfo Firpo-Betancourt, Damodara Rao Mendu, Susan Zolla-Pazner, Ken Cadwell, Jean-Frederic Colombel
doi: https://doi.org/10.1101/2021.03.15.21253615

Data Availability

This data will be shared upon request.

Back to top
Posted March 17, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Safety of administering biologics to IBD patients at an outpatient infusion center In New York City during the COVID-19 pandemic: Sars-CoV-2 seroprevalence and clinical and social characteristics
Serre-Yu Wong, Stephanie Gold, Emma K. Accorsi, Tori L. Cowger, Dean Wiseman, Reema Navalurkar, Rebekah Dixon, Drew S. Helmus, CiTI Study Group, Adolfo Firpo-Betancourt, Damodara Rao Mendu, Susan Zolla-Pazner, Ken Cadwell, Jean-Frederic Colombel
medRxiv 2021.03.15.21253615; doi: https://doi.org/10.1101/2021.03.15.21253615
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area